Mostrar el registro sencillo del ítem
A reverse evidence of rotavirus vaccines impact
dc.contributor.author | Martinón Torres, Federico | |
dc.contributor.author | Aramburo Caragol, Ángela | |
dc.contributor.author | Martinon Torres, Nazareth | |
dc.contributor.author | Cebey López, Miriam | |
dc.contributor.author | Seoane Pillado, María Teresa | |
dc.contributor.author | Redondo Collazo, Lorenzo | |
dc.contributor.author | Martinón Sánchez, José María | |
dc.date.accessioned | 2017-06-07T07:02:53Z | |
dc.date.available | 2017-06-07T07:02:53Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 2164-5515 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/2030 | |
dc.description.abstract | In 2010, and due to a quality problem identified in the vaccine manufacture, the rotavirus (RV) vaccination was withheld in Spain during 5 months. Our study aimed to evaluate the impact that this sudden cease had on rotavirus acute gastroenteritis (RAGE) hospitalizations. An increase in RAGE hospitalization was observed in parallel to the drop in vaccine coverage. Here, we report the first reverse evidence of rotavirus vaccine impact. | |
dc.language.iso | eng | |
dc.subject.mesh | Child, Preschool | |
dc.subject.mesh | Female | |
dc.subject.mesh | Gastroenteritis | |
dc.subject.mesh | Hospitalization | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Infant | |
dc.subject.mesh | Infant, Newborn | |
dc.subject.mesh | Male | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | Rotavirus Infections | |
dc.subject.mesh | Rotavirus Vaccines | |
dc.subject.mesh | Safety-Based Drug Withdrawals | |
dc.subject.mesh | Spain/epidemiology | |
dc.subject.mesh | Vaccination | |
dc.subject.mesh | Vaccine effectiveness | |
dc.subject.mesh | gastroenteritis | |
dc.subject.mesh | hospitalization | |
dc.subject.mesh | rotavirus infections | |
dc.subject.mesh | rotavirus vaccines | |
dc.title | A reverse evidence of rotavirus vaccines impact | |
dc.type | Artigo | es |
dc.authorsophos | Martinón-Torres, F. | |
dc.authorsophos | Aramburo, A. | |
dc.authorsophos | Martinón-Torres, N. | |
dc.authorsophos | Cebey, M. | |
dc.authorsophos | Seoane-Pillado, M. T. | |
dc.authorsophos | Redondo-Collazo, L. | |
dc.authorsophos | Martinón-Sánchez, J. M. | |
dc.identifier.doi | 10.4161/hv.24182 | |
dc.identifier.isi | 330380700022 | |
dc.identifier.pmid | 23836258 | |
dc.identifier.sophos | 12529 | |
dc.issue.number | 6 | |
dc.journal.title | Human Vaccines & Immunotherapeutics | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Pediatría | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Epidemioloxía | |
dc.page.initial | 1289 | |
dc.page.final | 91 | |
dc.relation.publisherversion | https://www.tandfonline.com/doi/pdf/10.4161/hv.24182?needAccess=true | |
dc.rights.accessRights | openAccess | |
dc.typesophos | Artículo Original | |
dc.volume.number | 9 |